Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SEM
SEM logo

SEM Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
16.680
Open
16.660
VWAP
16.66
Vol
962.35K
Mkt Cap
2.07B
Low
16.640
Amount
16.03M
EV/EBITDA(TTM)
9.18
Total Shares
124.01M
EV
4.27B
EV/OCF(TTM)
11.01
P/S(TTM)
0.37
Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.
Show More

Events Timeline

(ET)
2026-05-21
09:10:00
Select Medical and Carilion Clinic Partner to Build 50-Bed Rehab Hospital
select
2026-04-30 (ET)
2026-04-30
16:50:00
Sees FY25 Adjusted EBITDA at $520M-$540M
select
2026-04-30
16:40:00
Company Reports Q1 Revenue of $1.421B
select
2026-03-04 (ET)
2026-03-04
06:30:00
Benchmark Downgrades Select Medical to Hold
select
2026-03-04
04:40:00
Deutsche Bank Downgrades Select Medical to Hold, Price Target $16.50
select
2026-03-03 (ET)
2026-03-03
05:30:00
RBC Capital Downgrades Select Medical to Sector Perform, Price Target Cut to $16.50
select
2026-03-02 (ET)
2026-03-02
18:50:00
Select Medical Enters Agreement for $16.50 Acquisition by Consortium
select

News

Globenewswire
8.5
06-12Globenewswire
PinnedInvestigation Launched into Select Medical's Merger Deal
  • Merger Announcement: On March 2, 2026, Select Medical announced its acquisition for $16.50 per share, led by co-founder Robert A. Ortenzio and senior executives, with ties to a private equity firm, raising potential shareholder concerns about conflicts of interest.
  • Shareholder Rights Issues: The merger will convert all Select Medical shares into cash, but allows certain executives to rollover their stakes into the new entity, which excludes public shareholders, potentially leading to allegations of unfair treatment.
  • Investigation Rationale: Bleichmar Fonti & Auld LLP is investigating whether Select Medical's board and management breached their fiduciary duties during the merger negotiations and public disclosures aimed at securing shareholder approval, which could impact the legitimacy of the deal.
  • Voting Schedule: The merger requires shareholder approval, with a vote set for June 26, 2026, and if passed, it may limit shareholders' ability to further investigate the fairness of the transaction.
PRnewswire
8.5
06-12PRnewswire
Investor Rights Law Firm Investigates Merger Transactions
  • Merger Investigation: Halper Sadeh LLC is investigating the merger between Brink's Company and NCR Atleos Corporation, where Brink's shareholders are expected to own approximately 78% of the combined entity, potentially impacting shareholder rights and future earnings.
  • Cash Acquisition Proposal: Select Medical Holdings Corporation is being sold to a consortium led by its executives and directors for $16.50 per share in cash, which could significantly affect the financial interests of its shareholders.
  • Shareholder Rights Protection: Halper Sadeh LLC encourages Brink's and NCR shareholders to contact them to discuss their legal rights and options, indicating a strong commitment to protecting investor interests that may lead to increased transaction compensation or additional disclosures.
  • Legal Fee Arrangement: The law firm promises to handle related matters on a contingent fee basis without upfront costs, reducing legal risks for shareholders and enhancing their willingness to participate in the investigation.
Globenewswire
7.0
06-10Globenewswire
Investigation Launched into Select Medical Merger Deal
  • Shareholder Rights Investigation: Johnson Fistel, PLLP has initiated an investigation into whether the board of Select Medical Holdings breached its fiduciary duties in connection with the proposed sale to a consortium led by Robert A. Ortenzio, aiming to protect shareholder interests.
  • Merger Deal Details: On March 2, 2026, Select Medical announced a definitive merger agreement with Robert A. Ortenzio's consortium at a cash price of $16.50 per share, expected to close in mid-2026 pending shareholder and majority non-consortium approval.
  • Impact on Shareholder Rights: If consummated, the transaction will privatize Select Medical, leading to its shares being delisted from the NYSE, raising concerns about the fair treatment of minority shareholders and the overall value of their investments.
  • Law Firm Background: Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm that has recovered approximately $90.725 million for clients in securities class actions, demonstrating its effectiveness in advocating for investor rights and its significant influence in the legal landscape.
Globenewswire
7.0
06-08Globenewswire
Investigation into Select Medical's Acquisition Deal
  • Acquisition Investigation: Bleichmar Fonti & Auld LLP is investigating whether Select Medical Holdings Corporation's board and senior management breached their fiduciary duties to shareholders in connection with the company's pending sale at $16.50 per share, potentially impacting shareholder interests.
  • Acquisition Details: The deal is led by co-founder Robert A. Ortenzio and Senior Executive VP Martin F. Jackson, with certain executives allowed to rollover their shares into the post-merger entity, a privilege not extended to public shareholders, raising fairness concerns.
  • Shareholder Voting Schedule: The merger has been approved by a special committee, with a shareholder vote set for June 26, 2026, and the merger could close shortly thereafter, limiting shareholders' ability to investigate the fairness of the deal.
  • Legal Options for Shareholders: BFA encourages current shareholders to submit their information to explore legal options, with all representation on a contingency fee basis, indicating a commitment to protecting shareholder rights.
Globenewswire
8.5
06-05Globenewswire
Investigation Launched into Select Medical's Merger Deal
  • Merger Announcement: On March 2, 2026, Select Medical disclosed its agreement to be acquired for $16.50 per share, led by co-founder Robert A. Ortenzio and other executives, with ties to a private equity firm, raising concerns about shareholder interests.
  • Shareholder Rights Concerns: The merger will convert all Select Medical shares into cash, but select executives and their affiliates are allowed to rollover their stakes into the new entity, a move not extended to public shareholders, potentially questioning the fairness of the deal.
  • Investigation Rationale: Bleichmar Fonti & Auld LLP is investigating whether Select Medical's board and senior management breached their fiduciary duties during the merger negotiations and disclosures, which could impact shareholder decision-making.
  • Voting Timeline: The merger requires shareholder approval, with a vote scheduled for June 26, 2026; if the deal closes shortly after, it may limit shareholders' ability to further investigate the merger's fairness, increasing legal risks.
Globenewswire
2.0
06-03Globenewswire
Investigation into Select Medical's Board Actions
  • Merger Investigation: Bleichmar Fonti & Auld LLP is investigating potential breaches of fiduciary duties by Select Medical Holdings Corporation's board and senior management in connection with the company's pending sale for $16.50 per share, which may adversely affect shareholder interests.
  • Shareholder Vote Schedule: The merger has been approved by a special committee of Select Medical's board, with a shareholder vote scheduled for June 26, 2026, which could limit shareholders' ability to investigate the fairness of the merger if approved.
  • Executive Stock Arrangement: Post-merger, co-founder Robert A. Ortenzio and Senior Executive Vice President Martin F. Jackson are allowed to
Wall Street analysts forecast SEM stock price to rise
4 Analyst Rating
Wall Street analysts forecast SEM stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
17.00
Averages
18.75
High
21.00
Current: 0.000
sliders
Low
17.00
Averages
18.75
High
21.00
Mizuho
Ann Hynes
Outperform -> Neutral
downgrade
$17
AI Analysis
2026-05-12
Reason
Mizuho
Ann Hynes
Price Target
$17
AI Analysis
2026-05-12
downgrade
Outperform -> Neutral
Reason
Mizuho analyst Ann Hynes downgraded Select Medical to Neutral from Outperform with a price target of $16.50, down from $17. The company is being taken private with the deal expected to close in mid-2026, pending shareholder approval, the analyst tells investors in a research note. Mizuho views the $16.50 in cash per share price as fair.
RBC Capital
Outperform
maintain
$20 -> $19
2026-02-23
Reason
RBC Capital
Price Target
$20 -> $19
2026-02-23
maintain
Outperform
Reason
RBC Capital lowered the firm's price target on Select Medical to $19 from $20 and keeps an Outperform rating on the shares. The stock declined about 7% on Friday after the company reported a Q4 adjusted EBITDA miss and softer-than-expected 2026 guidance, though the firm is encouraged that management does not expect a material headwind related to the high-cost outlier threshold within its CIRH segment in 2026, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SEM
Unlock Now

Valuation Metrics

The current forward P/E ratio for Select Medical Holdings Corp (SEM.N) is 13.55, compared to its 5-year average forward P/E of 13.90. For a more detailed relative valuation and DCF analysis to assess Select Medical Holdings Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
13.90
Current PE
13.55
Overvalued PE
16.38
Undervalued PE
11.41

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.38
Current EV/EBITDA
9.10
Overvalued EV/EBITDA
11.38
Undervalued EV/EBITDA
9.39

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.50
Current PS
0.35
Overvalued PS
0.64
Undervalued PS
0.36

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

potential swing trade possibilities?
Intellectia · 22 candidates
Region: USPrice: $5.00 - $150.00Rsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Support Resistance Relationship: PriceAroundSupportMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
HOLX logo
HOLX
Hologic Inc
16.97B
VNOM logo
VNOM
Viper Energy Inc
16.56B
JHG logo
JHG
Janus Henderson Group PLC
7.93B
AL logo
AL
Air Lease Corp
7.28B
SEE logo
SEE
Sealed Air Corp
6.20B
PAGP logo
PAGP
Plains GP Holdings LP
5.55B
what stocks I would profit fast
Intellectia · 29 candidates
Region: USPrice: $2.00 - $50.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEWeek Price Change Pct: $5.00 - $80.00One Week Rise Prob: >= 60Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
DV logo
DV
DoubleVerify Holdings Inc
1.65B
INDO logo
INDO
Indonesia Energy Corp Ltd
78.68M
SEM logo
SEM
Select Medical Holdings Corp
2.02B
USGO logo
USGO
US GoldMining Inc
179.25M
GTE logo
GTE
Gran Tierra Energy Inc
232.25M
OUST logo
OUST
Ouster Inc
1.36B

Whales Holding SEM

E
Eversept Partners, L.P.
Holding
SEM
-3.26%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Select Medical Holdings Corp (SEM) stock price today?

The current price of SEM is 16.66 USD — it has increased 0

What is Select Medical Holdings Corp (SEM)'s business?

Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.

What is the price predicton of SEM Stock?

Wall Street analysts forecast SEM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SEM is18.75 USD with a low forecast of 17.00 USD and a high forecast of 21.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Select Medical Holdings Corp (SEM)'s revenue for the last quarter?

Select Medical Holdings Corp revenue for the last quarter amounts to 1.42B USD, increased 5.05

What is Select Medical Holdings Corp (SEM)'s earnings per share (EPS) for the last quarter?

Select Medical Holdings Corp. EPS for the last quarter amounts to 0.35 USD, decreased -20.45

How many employees does Select Medical Holdings Corp (SEM). have?

Select Medical Holdings Corp (SEM) has 30800 emplpoyees as of June 14 2026.

What is Select Medical Holdings Corp (SEM) market cap?

Today SEM has the market capitalization of 2.07B USD.